LENZI KAUB: Open Payments
NPI 1265024426 · GARDNER, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$323 in 10 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $193 · 2025 $323
Food & beverage: $323
| Company | Payments | Amount |
|---|---|---|
| MicroTransponder, Inc. | 1 | $158 |
| Otsuka America Pharmaceutical, Inc. | 2 | $29 |
| Novo Nordisk Inc | 1 | $28 |
| ABBVIE INC. | 1 | $21 |
| Ardelyx, Inc. | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| Cranial Technologies, Inc | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Amgen Inc. | 1 | $15 |
Products named: REXULTI, Wegovy, VRAYLAR, IBSRELA, TRELEGY ELLIPTA, Doc Band, BREZTRI, OTEZLA.
Industry payments across KS — which companies pay providers there.
